Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Alembic
FDA Approves DOXYCYCLINE HYCLATE — Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited announced the approval of its ANDA for Doxycycline Hyclate, solidifying its presence in the stable oral antimicrobial ...

Eli
FDA Approves OLUMIANT — Eli Lilly and Company

Eli Lilly and Company’s FDA approval of the oral rheumatoid arthritis medication OLUMIANT (baricitinib) is expected to bolster the company’s market sh...

Sun
FDA Approves YONSA — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries received FDA approval for its generic oral formulation of abiraterone acetate (NDA 210308) on May 22, 2018. The entry of...

SpecGx
FDA Approves OXYCODONE HYDROCHLORIDE — SpecGx LLC

SpecGx LLC announced FDA approval for its abuse-deterrent oxycodone hydrochloride tablets, positioning the company to compete for a slice of the gener...

Zydus
FDA Approves METHYLPREDNISOLONE — Zydus Lifesciences Limited

# FDA Approves Generic Methylprednisolone Oral Formulation from Zydus Lifesciences Zydus Lifesciences Limited has received FDA approval for its gener...

Kyowa
FDA Approves CRYSVITA — Kyowa Kirin, Inc.

# FDA Approves Kyowa Kirin's CRYSVITA for X-Linked Hypophosphatemia Treatment Kyowa Kirin, Inc. received FDA approval for CRYSVITA (burosumab), a fir...

ANI
FDA Approves Unknown Drug — ANI PHARMS

ANI PHARMS secured an FDA approval for ANDA 205509, signaling a key entry into the market with commercial potential expected to bolster the company's ...

Epic
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Epic Pharma, LLC

Epic Pharma, LLC has obtained FDA approval for ANDA 203863 to manufacture hydrocodone bitartrate and acetaminophen, broadening the generic availabilit...

RHODES
FDA Approves Unknown Drug — RHODES PHARMS

Rhodes Pharmaceuticals announced today that the FDA has granted approval for ANDA 207808, which, pending market entry, will allow the company to capit...

XIROMED
FDA Approves Unknown Drug — XIROMED

XIROMED announced today the approval by the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA202970), signaling a ...

Teva
FDA Approves PALONOSETRON HYDROCHLORIDE — Teva Parenteral Medicines, Inc.

Teva Parenteral Medicines announced the approval of its ANDA for palonosetron hydrochloride on March 23, 2018, which expands its U.S. portfolio with a...

Eywa
FDA Approves OXYCODONE AND ACETAMINOPHEN — Eywa Pharma Inc

Eywa Pharma Inc. has received final FDA approval for its ANDA 207510, allowing for the generic sale of the opioid combination oxycodone and acetaminop...

ALIGNSCIENCE
FDA Approves Unknown Drug — ALIGNSCIENCE PHARMA

AlignScience Pharma announced the FDA’s approval yesterday of its New Drug Application, holding significant market potential for commercialization. Th...

Westminster
FDA Approves ACYCLOVIR — Westminster Pharmaceuticals, LLC

Westminster Pharmaceuticals, LLC received FDA approval on March 7, 2018, for the Abbreviated New Drug Application (ANDA) #210401 for the oral version ...

ZYDUS
FDA Approves Unknown Drug — ZYDUS PHARMS

On February 27, 2018, Zydus Pharma received FDA approval for ANDA206798, signaling a significant opportunity to capture market share in the undetermin...

Janssen
FDA Approves ERLEADA — Janssen Products, LP

# FDA Approves Janssen's ERLEADA for Prostate Cancer Treatment Janssen Products, LP received FDA approval for ERLEADA (apalutamide), an oral androgen...

Gilead
FDA Approves BIKTARVY — Gilead Sciences, Inc.

Gilead Sciences, Inc. announced the approval of BIKTARVY (bictegravir sodium/emtricitabine/tenofovir alafenamide fumarate), a fully-supply single-tabl...

XLCare
FDA Approves OXYMORPHONE HYDROCHLORIDE — XLCare Pharmaceuticals, Inc.

The FDA has approved XLCare Pharmaceuticals, Inc.’s abbreviated new drug application (ANDA 210175) for oral oxyymorphone hydrochloride, injecting the ...

Strides
FDA Approves PIROXICAM — Strides Pharma Science Limited

Strides Pharma Science Limited’s approval for the generic NSAID Piroxicam adds a new competitor to the US market, likely increasing pricing pressure o...

Westminster
FDA Approves CELECOXIB — Westminster Pharmaceuticals, LLC

Westminster Pharmaceuticals announced the FDA approval of its Abbreviated New Drug Application for celecoxib oral tablets in strengths of 200 mg and 1...